FDA approves new $1,125-a-pill hepatitis C drug

October 10, 2014 7:05 PM

16 0

FDA approves new $1,125-a-pill hepatitis C drug

WASHINGTON -- Federal health officials have approved a daily pill that can cure the most common form of hepatitis C without the grueling pill-and-injection cocktail long used to treat the virus.

But the drug's $1,125-per-pill price is sure to increase criticism of drugmaker Gilead Sciences, whose pricing strategy for an older hepatitis drug has already drawn scorn from patient groups, insurers and politicians worldwide.

Read more

To category page